| Prev Close: | 12.14 |
|---|---|
| Open: | N/A |
| Bid: | 11.00 x 800 |
| Ask: | N/A |
| 1y Target Est: | 16.13 |
| Beta: | 1.74 |
| Next Earnings Date: | 17-Jul-13 |
| Day's Range: | N/A - N/A |
|---|---|
| 52wk Range: | 10.01 - 19.67 |
| Volume: | 0 |
| Avg Vol (3m): | 1,143,630 |
| Market Cap: | 1.31B |
| P/E (ttm): | N/A |
| EPS (ttm): | -1.22 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Almirall CEO Eyes $11.6 Billion COPD Market Smokers Fuelat Bloomberg(Tue, Jun 18)
- IRWD Launches Constella in EuropeZacks(Mon, Jun 17)
- Synergy Pharma rises as analyst starts coverageAP(Mon, Jun 17)
- 4 Stocks Underperforming Today In The Health Services Industryat TheStreet(Wed, Jun 12)
- IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online(Wed, Jun 12)
- IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Wed, Jun 5)
- Ironwood Pharmaceuticals Announces Partial Exercise of Underwriters’ Option in Public Offering of Common StockBusiness Wire(Tue, Jun 4)
- Ironwood Pharmaceuticals, Inc. - Shareholder/Analyst Callat Seeking Alpha(Tue, Jun 4)
- Movers roundup: Facebook, Michael KorsAP(Thu, May 30)
- Ironwood Pharma rises following analyst upgradeAP(Thu, May 30)
- Ironwood Pharmaceuticals (IRWD) Shares Cross Above 200 DMAat Forbes(Thu, May 30)
- 3 Horrendous Health-Care Stocks This Weekat Motley Fool(Sat, May 25)
- Positive Data from Synergy PharmaZacks(Fri, May 24)
- IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Fri, May 24)
- Ironwood Pharma Prices Stock OfferingZacks(Thu, May 23)
Press Releases
- Ironwood Pharmaceuticals Announces Partial Exercise of Underwriters’ Option in Public Offering of Common StockBusiness Wire(Tue, Jun 4)
- Ironwood Pharmaceuticals Prices Public Offering of Common StockBusiness Wire(Tue, May 21)
- Ironwood Pharmaceuticals Announces Proposed Public Offering of Common StockBusiness Wire(Mon, May 20)
Reports
- IRWD: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(Jun 19)
- ValuEngine Industry Report for Medical-drugsValuEngine, Inc.(Jun 19)
- Wright Investors Service Comprehensive Report for Ironwood Pharmaceuticals IncorporationWright Reports(Jun 18)